1. Home
  2. ENVB vs SOPA Comparison

ENVB vs SOPA Comparison

Compare ENVB & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • SOPA
  • Stock Information
  • Founded
  • ENVB 1994
  • SOPA 2018
  • Country
  • ENVB United States
  • SOPA Singapore
  • Employees
  • ENVB N/A
  • SOPA N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • SOPA EDP Services
  • Sector
  • ENVB Health Care
  • SOPA Technology
  • Exchange
  • ENVB Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • ENVB 3.2M
  • SOPA 3.8M
  • IPO Year
  • ENVB N/A
  • SOPA 2021
  • Fundamental
  • Price
  • ENVB $1.21
  • SOPA $1.22
  • Analyst Decision
  • ENVB Strong Buy
  • SOPA Strong Buy
  • Analyst Count
  • ENVB 1
  • SOPA 1
  • Target Price
  • ENVB $10.00
  • SOPA $15.00
  • AVG Volume (30 Days)
  • ENVB 419.0K
  • SOPA 969.0K
  • Earning Date
  • ENVB 05-14-2025
  • SOPA 05-20-2025
  • Dividend Yield
  • ENVB N/A
  • SOPA N/A
  • EPS Growth
  • ENVB N/A
  • SOPA N/A
  • EPS
  • ENVB N/A
  • SOPA N/A
  • Revenue
  • ENVB N/A
  • SOPA $6,731,955.00
  • Revenue This Year
  • ENVB N/A
  • SOPA $26.32
  • Revenue Next Year
  • ENVB N/A
  • SOPA N/A
  • P/E Ratio
  • ENVB N/A
  • SOPA N/A
  • Revenue Growth
  • ENVB N/A
  • SOPA N/A
  • 52 Week Low
  • ENVB $1.01
  • SOPA $0.64
  • 52 Week High
  • ENVB $11.97
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 38.00
  • SOPA 51.19
  • Support Level
  • ENVB $1.11
  • SOPA $1.07
  • Resistance Level
  • ENVB $1.31
  • SOPA $1.67
  • Average True Range (ATR)
  • ENVB 0.11
  • SOPA 0.15
  • MACD
  • ENVB 0.04
  • SOPA -0.00
  • Stochastic Oscillator
  • ENVB 26.33
  • SOPA 25.00

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: